3B Scientific Buys iSimulate

3B Scientific, a portfolio company of J.H. Whitney Capital Partners, LLC and a manufacturer and marketer of anatomical models and medical simulation products for healthcare and patient education, has entered into an agreement to acquire iSimulate Pty. Ltd., a developer of clinical education technology offering smart and cost effective medical simulation solutions.
 
“iSimulate has revolutionized simulation training in healthcare through its creative simulation solutions including ALSi, REALITi, CTGi and AURiS,” said Todd Murray, CEO of 3B Scientific. “We are extremely excited to further develop the 3B Scientific platform and add the great products and people of iSimulate to our company. Our 3B Scientific global distribution footprint including fourteen commercial locations is uniquely positioned to further support and accelerate the growth of iSimulate products worldwide.”
 
iSimulate CEO Peter McKie added, “We are proud of the progress we have made with our company and Anthony, Bobby, and I decided that the 3B Scientific team would be the best partner for us to expand and grow the business in the years to come. We are excited for the next step in our journey and appreciate the support from our customers worldwide. We look forward to working closely with Todd and his team.”
 
After the closing, Peter McKie, Anthony Lewis, and Bobby Syed will remain active in the company and continue to drive the business plan for iSimulate. A significant emphasis for strong growth and the development of the product pipeline lies in the active collaboration from and partnership with the experts from 3B Scientific and Cardionics. iSimulate operations will remain unchanged and will continue to be based in both Canberra, Australia and Albany, N.Y.
 
The healthcare simulation market has experienced significant growth in the past decade and is estimated to reach $2.27B by 2021, according to a 2016 MarketsandMarkets report.
The acquisition is anticipated to be consummated in the first quarter of 2020.